Evidence map›Paper›PMID 22615397›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Multiplex assay for condition-dependent changes in protein-protein interactions.

Ulrich Schlecht, Molly Miranda, Sundari Suresh, Ronald W Davis, Robert P St Onge

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Three decades of protein-fragment complementation.Nature reviews. Molecular cell biology · 2025
    Article
  4. Article
  5. Evaluation of Antifungal Selective Toxicity UsingJournal of fungi (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Phosphatidylinositol 3,5-bisphosphate regulates CaTraffic (Copenhagen, Denmark) · 2020
    Article
  15. Article
  16. Protein Topology Prediction Algorithms Systematically Investigated in the Yeast Saccharomyces cerevisiae.BioEssays : news and reviews in molecular, cellular and developmental biology · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ulrich SchlechtStanford Genome Technology Center, Department of Biochemistry, Stanford University, Palo Alto, CA 94304, USA.
Molly Miranda
Sundari Suresh
Ronald W Davis
Robert P St Onge
Stanford University · US

Funding

Identification of Small-Molecule Inhibitors of Protein-Protein InteractionsR21HG005785 · NHGRI · STANFORD UNIVERSITY · PI DAVIS, RONALD WAYNE · 2010 to 2011
$440k
NHGRI NIH HHS R21 HG005785NHGRI NIH HHS R21HG005785-01
6 · The paper itself

Abstract

Changes in protein-protein interactions that occur in response to environmental cues are difficult to uncover and have been poorly characterized to date. Here we describe a yeast-based assay that allows many binary protein interactions to be assessed in parallel and under various conditions. This method combines molecular bar-coding and tag array technology with the murine dihydrofolate reductase-based protein-fragment complementation assay. A total of 238 protein-fragment complementation assay strains, each representing a unique binary protein complex, were tagged with molecular barcodes, pooled, and then interrogated against a panel of 80 diverse small molecules. Our method successfully identified specific disruption of the Hom3:Fpr1 interaction by the immunosuppressant FK506, illustrating the assay's capacity to identify chemical inhibitors of protein-protein interactions. Among the additional findings was specific cellular depletion of the Dst1:Rbp9 complex by the anthracycline drug doxorubicin, but not by the related drug idarubicin. The assay also revealed chemical-induced accumulation of several binary multidrug transporter complexes that largely paralleled increases in transcript levels. Further assessment of two such interactions (Tpo1:Pdr5 and Snq2:Pdr5) in the presence of 1,246 unique chemical compounds revealed a positive correlation between drug lipophilicity and the drug response in yeast.

Indexed as

AnimalsComputational BiologyDNA-Binding ProteinsMiceMicroarray AnalysisProtein Interaction MappingProtein Interaction MapsReal-Time Polymerase Chain ReactionReceptors, Formyl PeptideSaccharomyces cerevisiae ProteinsSmall Molecule LibrariesTacrolimusTetrahydrofolate DehydrogenaseYeastsDNA-Binding ProteinsDST1 protein, S cerevisiaeFpr1 protein, mouseReceptors, Formyl PeptideSaccharomyces cerevisiae ProteinsSmall Molecule LibrariesTacrolimusTetrahydrofolate Dehydrogenase

Identifiers

PMID22615397
PMCPMC3384208
OpenAlexW2153618281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.